2016 International Congress Archives

[18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer’s disease

J.B. Rowe, P. Vázquez Rodríguez, Y.T. Hong, R.J. Borchert, S. Sami, W.R. Bevan-Jones, S.P. Jones, R. Arnold, A. Surendranathan, E. Mak, S. Li, T. Fryer, J. O'Brien, L. Passamonti (Cambridge, United Kingdom)
α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients

G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)
α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease

H. Sumikura, J. Fujigasaki, Y. Nakano, A. Uchino, Y. Saito, H. Mochizuki, S. Murayama (Tokyo, Japan)
“Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia

S. Sekimoto, G. Oyama, T. Jo, A. Nakajima, Y. Shimo, M. Nakajima, A. Umemura, M. Ito, H. Arai, N. Hattori (Bunkyo-ku, Japan)
“Words untold”

P.M. Iyer, B. McGuiness, J. Scott, S. Manning, A. Chalisseri, D. Olszewska, M. Farrell, T. Lynch (Dublin, Ireland)
"Are patients with familial ET distinct from those with sporadic ET? Insight from 250 patients"

M. Manjunath, A. Lenka, K. Jhunjhunwala, K.S. Bhalsing, P.K. Pal (Bengaluru, India)
"Atypical" atypical parkinsonism

S.T. Hirschbichler, R. Erro, M. Stamelou, C. Ganos, B. Balint, K.P. Bhatia (London, United Kingdom)
DYT2 screening in early-onset isolated dystonia in Italy

C. Reale, F. Invernizzi, M. Carecchio, S. Petrucci, G. Zorzi, F. Zibordi, M. Ginevrino, E.M. Valente, N. Nardocci, B. Garavaglia (Milan, Italy)
In vivo evaluation of tau pathologies in patient with progressive supranuclear palsy and healthy subjects with [¹¹C]PBB3-PET

H. Endo, H. Shimada, Y. Kimura, M. Ichise, M. Ono, H. Shinotoh, F. Niwa, S. Kitamura, K. Takahata, S. Hirano, S. Koga, D.W. Dickson, N. Sahara, M. Yamada, M. Higuchi, T. Toda, T. Suhara (Chiba, Japan)
SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families

I.A. Meijer, L.J. Azcona, H. Darvish, C. Paisán-Ruiz (New York, NY, USA)

2016 International Congress

[18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer’s disease

α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients

α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease

“Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia

“Words untold”

"Are patients with familial ET distinct from those with sporadic ET? Insight from 250 patients"

"Atypical" atypical parkinsonism

DYT2 screening in early-onset isolated dystonia in Italy

In vivo evaluation of tau pathologies in patient with progressive supranuclear palsy and healthy subjects with [¹¹C]PBB3-PET

SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families